Dexmedetomidine Attenuates the Microcirculatory Derangements Evoked by Experimental Sepsis
Open Access
- 1 March 2015
- journal article
- critical care-medicine
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesiology
- Vol. 122 (3), 619-630
- https://doi.org/10.1097/aln.0000000000000491
Abstract
Background: Dexmedetomidine, an α-2 adrenergic receptor agonist, has already been used in septic patients although few studies have examined its effects on microcirculatory dysfunction, which may play an important role in perpetuating sepsis syndrome. Therefore, the authors have designed a controlled experimental study to characterize the microcirculatory effects of dexmedetomidine in an endotoxemia rodent model that allows in vivo studies of microcirculation. Methods: After skinfold chamber implantation, 49 golden Syrian hamsters were randomly allocated in five groups: (1) control animals; (2) nonendotoxemic animals treated with saline; (3) nonendotoxemic animals treated with dexmedetomidine (5.0 μg kg−1 h−1); (4) endotoxemic (lipopolysaccharide 1.0 mg/kg) animals treated with saline; and (5) endotoxemic animals treated with dexmedetomidine. Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables and venular leukocyte rolling and adhesion. Mean arterial blood pressure, heart rate, arterial blood gases, and lactate concentrations were also documented. Results: Lipopolysaccharide administration increased leukocyte rolling and adhesion and decreased capillary perfusion. Dexmedetomidine significantly attenuated these responses: compared with endotoxemic animals treated with saline, those treated with dexmedetomidine had less leukocyte rolling (11.8 ± 7.2% vs. 24.3 ± 15.0%; P < 0.05) and adhesion (237 ± 185 vs. 510 ± 363; P < 0.05) and greater functional capillary density (57.4 ± 11.2% of baseline values vs. 45.9 ± 11.2%; P < 0.05) and erythrocyte velocity (68.7 ± 17.6% of baseline values vs. 54.4 ± 14.8%; P < 0.05) at the end of the experiment. Conclusions: Dexmedetomidine decreased lipopolysaccharide-induced leukocyte–endothelial interactions in the hamster skinfold chamber microcirculation. This was accompanied by a significant attenuation of capillary perfusion deficits, suggesting that dexmedetomidine yields beneficial effects on endotoxemic animals’ microcirculation.Keywords
This publication has 41 references indexed in Scilit:
- Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trialCritical Care, 2010
- To scale or not to scale: the principles of dose extrapolationBritish Journal of Pharmacology, 2009
- Central sympatholytics prolong survival in experimental sepsisCritical Care, 2009
- Sedation improves early outcome in severely septic Sprague Dawley ratsCritical Care, 2009
- Antinociception occurs with a reversal in α2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatoryEuropean Journal of Pharmacology, 2008
- Resuscitating the Microcirculation in Sepsis: The Central Role of Nitric Oxide, Emerging Concepts for Novel Therapies, and Challenges for Clinical TrialsAcademic Emergency Medicine, 2008
- Physiology and immunology of the cholinergic antiinflammatory pathwayJCI Insight, 2007
- Comparison between multiple behavioral effects of peripheral ethanol administration in rats: Sedation, ataxia, and bradykinesiaLife Sciences, 2006
- Cap Image - ein neuartiges computerunterstütztes Videobildanalysesystem für die dynamische Kapillarmikroskopie - Cap Image - A Newly-developed Computer-aided Videoframe Analysis System for Dynamic CapillaroscopyBiomedizinische Technik/Biomedical Engineering, 1997
- Technical report—a new chamber technique for microvascular studies in unanesthetized hamstersZeitschrift für Die Gesamte Experimentelle Medizin, 1980